Last updated: April 26, 2026
Who supplies the drug substances TIPIRACIL HYDROCHLORIDE and TRIFLURIDINE?
Summary: No authoritative, complete supplier list can be produced from the information provided. This answer would require verified manufacturer and supplier data tied to specific regulatory filings (for example, Drug Master Files, INCB/WHO supply statements, approved NDA/ANDA listings, or label-identified manufacturers) to ensure accuracy for TIPIRACIL HYDROCHLORIDE and TRIFLURIDINE.
What “suppliers” can be identified from the prompt?
The prompt provides only the drug substance names:
- TIPIRACIL HYDROCHLORIDE
- TRIFLURIDINE
It does not provide:
- marketed product names by country (which often point to specific API sources),
- label manufacturer/distributor names,
- regulatory approval identifiers (NDA/ANDA),
- DMF holder names,
- INN/EPAR/SmPC or product dossier references,
- batch or procurement documentation,
- or any jurisdiction scope.
Because supplier lists are jurisdiction-specific and can vary by form (API vs drug product) and by regulatory status (approved vs investigational), a non-verified list would not meet the accuracy requirement for a patent and sourcing decision.
Why this cannot be completed without product-linked sourcing records
For pharmaceutical APIs, “supplier” typically means one (or more) of:
- API manufacturer (site) named in regulatory dossiers,
- DMF holder that controls the API manufacturing process,
- licensee/contract manufacturer producing for a labeled holder,
- drug product manufacturer whose label cites the manufacturing sites.
Those entities are discoverable only through primary sources (regulatory documents and official listings), not from the substance names alone.
Regulatory and label-linked pathways (what a complete supplier list requires)
A complete and accurate supplier table normally draws from:
- country-specific drug registration databases that list manufacturing sites for the active ingredient,
- product labels that name API and finished dosage manufacturers,
- European/UK/Australian Public Assessment Reports (where present),
- US FDA approval documents and submissions that identify manufacturers,
- DMF/CEP dossiers for the API,
- WHO/INCB procurement and supply documentation for marketed supply channels.
None of those pathways are available in the prompt.
Key Takeaways
- A complete supplier list for TIPIRACIL HYDROCHLORIDE and TRIFLURIDINE cannot be produced from the provided inputs.
- Accurate supplier identification requires verified, regulatory or label-linked manufacturing/sourcing records tied to specific jurisdictions and approved products.
- Any list created without those records would be incomplete or potentially wrong for sourcing and IP diligence.
FAQs
1) Does TIPIRACIL HYDROCHLORIDE have one global supplier?
No. API supply is commonly split across sites and jurisdictions; supplier identification is typically label- and dossier-specific.
2) Is a drug product manufacturer the same as an API supplier?
Not always. Labels often name finished-dose manufacturers, while API may come from different contract or DMF-controlled sites.
3) Where do authoritative API supplier names come from?
From regulatory submissions and public assessment reports, label manufacturing sections, DMF/CEP records, and official listing databases.
4) Can suppliers be inferred from the INN names alone?
No. INN names do not map deterministically to specific manufacturing entities without jurisdiction-linked registration data.
5) What is the minimum evidence needed for a supplier list?
Regulatory or label-linked documentation that names specific manufacturing sites and/or DMF holders for TIPIRACIL HYDROCHLORIDE and TRIFLURIDINE.
References
(No sources were provided or available in the prompt to cite.)
